1604563

Rivaroxaban Related Compound D

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): 1,3-Bis[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]urea
• Empirische Formel (Hill-System): C₂₉H₃₂N₆O₉
• CAS-Nummer: 1365267-35-1
• Molekulargewicht: 608.60
• MDL number: MFCD28358884
• UNSPSC Code: 41116107
• NACRES: NA.24

Eigenschaften

• SMILES string: N3(C[C@@H](OC3=O)CNC(=O)NCC4OC(=O)N(C4)c5ccc(cc5)N6CCOCC6=O)c1ccc(cc1)N2CCOCC2=O
• InChI: 1S/C29H32N6O9/c36-25-17-41-11-9-32(25)19-1-5-21(6-2-19)34-15-23(43-28(34)39)13-30-27(38)31-14-24-16-35(29(40)44-24)22-7-3-20(4-8-22)33-10-12-42-18-26(33)37/h1-8,23-24H,9-18H2,(H2,30,31,38)/t23-,24?/m0/s1
• InChI key: RMYVVSKNFAMRGJ-UXMRNZNESA-N
• API family: rivaroxaban
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• storage temp.: 2-8°C

Beschreibung

General description

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Application

Rivaroxaban Related Compound D USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Rivaroxaban

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Other Notes

Sales restrictions may apply.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable